Journal of Stem Cell Research & Therapy

Zhang Y, Liu C, Barbier O, Smalling R, Tsuchiya H, et al. (2016) Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function. Scientific reports.

Youssef A, Aboalola D, Han VK (2017) The Roles of Insulin-Like Growth Factors in Mesenchymal Stem Cell Niche. Stem Cells International.

Matrone G, Tucker CS, Denvir MA (2016) Cardiomyocyte proliferation in zebrafish and mammals: lessons for human disease. Cellular and Molecular Life Sciences.

Lepperhof V, Polchynski O, Kruttwig K, Brüggemann C, Neef K (2014) Bioluminescent Imaging of Genetically Selected Induced Pluripotent Stem.

Kloner RA, Dai W, Shi J, Hale S, Csete M (2015) Rebuilding the infarcted heart with noncellular material.

Kloner RA, Shi J, Dai W (2015) New therapies for reducing post-myocardial left ventricular remodeling. Annals of translational medicine.

Florczyk U, Józkowicz A, Dulak J (2013) Nrf2 transcription factor and heme oxygenase-1 as modulators of vascular injury and angiogenesis. InAngiogenesis and Vascularisation pp. 213-239.

Si X, Liu X, Li J, Wu X (2014) Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury. International journal of clinical and experimental pathology 8: 12368-12378.

Locatelli P, Olea FD, Hnatiuk A, De Lorenzi A, Cerdá M, et al. (2015) Mesenchymal stromal cells overexpressing vascular endothelial growth factor in ovine myocardial infarction. Gene therapy 22: 449-457.

Dai W, Kay GL, Kloner RA (2014) The therapeutic effect of cell transplantation versus noncellular biomaterial implantation on cardiac structure and function following myocardial infarction. Journal of cardiovascular pharmacology and therapeutics.

Luo J, Weaver MS, Cao B, Dennis JE, Van Biber B,et al. (2014) Cobalt Protoporphyrin Pretreatment Protects Human Embryonic Stem Cell‐Derived Cardiomyocytes From Hypoxia/Reoxygenation Injury In Vitro and Increases Graft Size and Vascularization In Vivo. Stem cells translational medicine 3: 734-744.

Lepperhof V, Polchynski O, Kruttwig K, Brüggemann C, Neef K, et al. (2014) Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients. PloS one 9: e107363.

Fuentes TI, Appleby N, Tsay E, Martinez JJ, Bailey L, et al. (2013) Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability. PloS one 8: e77464.

Kozakowska M, Szade K, Dulak J, Jozkowicz A (2014) Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs. Antioxidants & redox signaling 20: 1827-1850.

Fuentes T, Kearns-Jonker M (2013) Endogenous cardiac stem cells for the treatment of heart failure. Stem Cells Cloning 6: 1-2.

D’souza N, Rossignoli F, Golinelli G, Grisendi G, Spano C, et al. (2015) Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies. BMC medicine 13: 186.

Hou X, Appleby N, Fuentes T, Longo LD, Bailey LL, et al. (2012) Isolation, characterization, and spatial distribution of cardiac progenitor cells in the sheep heart. Journal of clinical & experimental cardiology.

Wang H, Yang YF, Zhao L, Xiao FJ, Zhang QW, et al. (2013). Hepatocyte growth factor gene-modified mesenchymal stem cells reduce radiation-induced lung injury. Human gene therapy 24: 343-353.

Taimeh Z, Loughran J, Birks EJ, Bolli R (2013) Vascular endothelial growth factor in heart failure. Nature Reviews Cardiology 10: 519-530.

Cesselli D, Aleksova A, Mazzega E, Caragnano A, Beltrami AP (2017) Cardiac stem cell aging and heart failure. Pharmacological Research.